Bone Biologics Announces Pricing of Public Offering

Bone Biologics is currently focusing its development efforts for its bone graft substitute product on bone regeneration in spinal fusion.

Intelligent Implants Gains Financing

The company's SmartFuse technology platform was designed to remotely stimulate, control and monitor bone growth.

ReVivo Medical Raises $2 Million for FDA Sanctioned Clinical Trial

The 50-patient study will support an application for clearance of anterior cervical plates and interbody cages for commercial use.

Catalyst OrthoScience Gains Funding to Support Shoulder System

Funding will support innovation and growth as demand for the Archer Shoulder Replacement system increases.

CoreBone Raises Funds for Bioactive Bone Graft

The investment will be used to extend CoreBone's commercial global presence, primarily in China, with coral-based bone graft.

Paragon 28 Files for $100 Million IPO

Paragon 28 is focused on orthopedic solutions, procedural approaches and instrumentation cover a wide range of foot and ankle ailments.

Gramercy Extremity Orthopedics Raises $9.83 Million in Funding

The funding will support technology infrastructure and continued product expansion with specific focus on the U.S. extremity market.

Locate Bio Closes £10 Million Funding Round

Proceeds will further advance the company's regenerative medicine pipeline of orthobiologic products.

Onkos Surgical Raises $15 Million in Funding

Proceeds will support development, commercialization and manufacturing growth in surgical solutions for musculoskeletal oncology and complex orthopedics.

OsteoCentric Technologies Secures $30 Million in Growth Capital

Funds will support launch of new trauma products and further address implant instability across all orthopedic specialties.